The press should treat such studies with skepticism

Another one: a worked-up panic about anti-depressants and autism. David Auerbach reports at Slate:

The alarm has been sounded: Antidepressants cause autism! Or so one could easily think based on a new study in JAMA Pediatrics. Four researchers in Quebec conclude that “the use of antidepressants, specifically selective serotonin reuptake inhibitors [SSRIs], during the second and/or third trimester increases the risk of [autism spectrum disorder] in children.” In a ResearchGate interview, study senior author and perinatal pharmacoepidemiologist Anick Bérard of the Université de Montréal and the CHU Sainte-Justine Research Centre firmly advocated avoiding antidepressant use during pregnancy: “Depression needs to be treated during pregnancy but with something other than antidepressants in the majority of cases. The risk/benefit ratio is clearly leaning towards no use.”

Risk to whom and benefit to whom? Depression can be a very serious health problem; it can be fatal.

…other researchers have stressed a note of caution about the new antidepressant study and its methods. Yet even these dissenting voices do not, I think, go far enough.

Study co-author Bérard, it turns out, has been criticized by a federal judge for cherry-picking results to link antidepressants to birth defects. The press should treat such studies with skepticism rather than leading with their findings. Sober pieces in Science, Wired, and NPR rightly questioned whether the study was significant and whether Bérard’s advocacy for stopping antidepressant usage during pregnancy was justified. In particular, Emily Underwood in Science wisely led off by writing “Many epidemiologists and psychiatrists say the study, published today in JAMA Pediatrics, is flawed and will cause unnecessary panic,” which is the most important point to make about this study. But too many journalists failed to make this point, and with autism research, such credulity is downright dangerous.

And dangerous for whom? In this case, women; pregnant women.

In response to such critiques, Bérard told NPR, “We have to be vigilant even if the risk is small,” and told me in an email: “You need to consider other treatment options such as exercise or psychotherapy,” and again emphasized the supposed risk. This is misleading, however, since treatment is a matter of balancing competing risks, and the study runs the risk of playing up one unproven danger to the exclusion of far more established dangers—such as the impact of untreated or insufficiently treated depression. Bérard’s position smacks too much of banning liquids on airplanes and making people take off their shoes in airport lines—but with far worse potential consequences if women are persuaded to stop antidepressants that they genuinely need. Exercise and psychotherapy might be effective substitutes for some, but expectant mothers should make that decision without the unjustified specter of autism hanging over them.

And is it just random that it’s women who are being told to give up anti-depressants here? Is it just random that it’s women who are being told to forget about their own health and well-being because their bodies now belong to the pregnancy?

In Science, Emily Underwood reports that Bérard “serves as a consultant for plaintiffs in litigations involving antidepressants and birth defects,” suggesting that she might not have approached the study with a disinterested attitude toward antidepressants. In 2014, she served as a plaintiffs’ expert witness in the Pennsylvania Zoloft birth defects lawsuit against Pfizer, until her testimony was excluded by Judge Cynthia M. Rufe on the grounds that Bérard’s methods were “not scientifically sound.” In her ruling, Rufe excoriates Bérard for 25 pages, writing:

The Court holds that Dr. Bérard’s opinion is not grounded in the methods and principles of science … [the report’s] methodology is not reliable or scientifically sound. … Dr. Bérard takes a position in this litigation which is contrary to the opinion she has expressed to her peers in the past, relies upon research that her peers do not recognize as supportive of her litigation opinion, and uses principles and methods which are not recognized by the relevant scientific community and are not subject to scientific verification…

Not helpful.

9 Responses to “The press should treat such studies with skepticism”